Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in Stock

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00.

Cipher Pharmaceuticals Stock Down 3.7 %

CPH opened at C$12.65 on Tuesday. Cipher Pharmaceuticals Inc. has a 12 month low of C$7.90 and a 12 month high of C$19.69. The business has a 50-day moving average of C$12.88 and a two-hundred day moving average of C$14.42. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The stock has a market capitalization of C$227.11 million, a price-to-earnings ratio of 13.97 and a beta of 1.20.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.